source Post navigation Exploring the effect of dapagliflozin on coronary inflammation in type 2 diabetes patients based on the coronary artery perivascular fat attenuation index – BioMed Central Immune Protein Deficiency May Be Key to Type 1 Diabetes Development – University of Missouri School of Medicine
